Laboratorios Farmaceuticos Rovi S.A. Logo

Laboratorios Farmaceuticos Rovi S.A.

Integrated pharma firm developing prescription drugs and offering contract manufacturing services.

ROVI | MC

Overview

Corporate Details

ISIN(s):
ES0157261019
LEI:
95980020140005936480
Country:
Spain
Address:
JULIAN CAMARILLO 35, 28037 Madrid
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorios Farmaceuticos Rovi S.A. is a specialized and fully integrated pharmaceutical company founded in 1946. The company's core activities encompass the research, development, manufacturing, and commercialization of a range of pharmaceutical products, with a focus on prescription and hospital-grade medicines. In addition to its proprietary product pipeline, ROVI also provides contract manufacturing services to third parties, offering a comprehensive suite of solutions including production, testing, packaging, and storage.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-18 00:00
La Sociedad informa sobre los acuerdos adoptados por su Junta General Ordinaria…
Spanish 152.8 KB
2025-05-08 07:56
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-05-08 07:54
ROVI informa sobre la concesión de una subvención en su favor para el desarroll…
Spanish 171.1 KB
2025-05-08 07:39
La Compañía hace pública la presentación relativa a los resultados financieros …
Spanish 957.7 KB
2025-05-08 07:35
La Compañía hace público el comunicado de prensa relativo a los resultados fina…
Spanish 631.0 KB
2025-05-08 00:00
La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordina…
Spanish 488.2 KB
2025-04-04 10:27
Operaciones sobre acciones propias efectuadas en el primer trimestre de 2025 en…
Portuguese 219.9 KB
2025-03-25 10:03
La Sociedad hace pública de nuevo la presentación en español relativa a la actu…
Spanish 2.3 MB
2025-03-25 08:00
La Sociedad hace pública la presentación relativa a la actualización de su estr…
Spanish 2.3 MB
2025-02-25 07:54
La Sociedad informa sobre los acuerdos adoptados por su Consejo de Administraci…
Spanish 85.6 KB
2025-02-25 07:49
La Sociedad hace pública la presentación de los resultados financieros del ejer…
Spanish 1.4 MB
2025-02-25 07:47
La Sociedad hace público el comunicado de prensa relativo a los resultados fina…
Spanish 672.9 KB
2025-02-25 07:15
La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del …
Spanish 236.7 KB
2025-02-25 07:10
La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2024
Spanish 3.5 MB
2025-02-25 00:00 English 615.4 KB

Automate Your Workflow. Get a real-time feed of all Laboratorios Farmaceuticos Rovi S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Laboratorios Farmaceuticos Rovi S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Laboratorios Farmaceuticos Rovi S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea
243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea
084110
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea
061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium
HYL
HYUNDAI BIOLAND Co.,Ltd. Logo
Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.
South Korea
052260
Hyupjin Co., Ltd. Logo
A patient-focused healthcare company supplying high-quality products for a healthy life.
South Korea
138360
iBio, Inc. Logo
AI-powered biotech developing antibody therapeutics for cardiometabolic diseases and obesity.
United States of America
IBIO
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea
175250

Talk to a Data Expert

Have a question? We'll get back to you promptly.